-
EP0984773
European procedure
Extract from the Register of European Patents
EP About this file: EP0984773
| EP0984773 - PHARMACEUTICAL FORMULATION OF OMEPRAZOLE [Right-click to bookmark this link] | Status | Opposition rejected Status updated on 12.07.2013 Database last updated on 21.01.2025 | Most recent event Tooltip | 11.01.2019 | Change - classification | published on 13.02.2019 [2019/07] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2000/19] |
| Former [2000/11] | For all designated states Astra Aktiebolag 151 85 Södertälje / SE | Inventor(s) | 01 /
ERICKSON, Magnus Astra Hässle AB S-431 83 Mölndal / SE | 02 /
JOSEFSSON, Lars Astra Hässle AB S-431 83 Mölndal / SE | [2000/11] | Application number, filing date | 98924700.2 | 18.05.1998 | [2000/11] | WO1998SE00922 | Priority number, date | SE19970002000 | 28.05.1997 Original published format: SE 9702000 | [2000/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9853803 | Date: | 03.12.1998 | Language: | EN | [1998/48] | Type: | A1 Application with search report | No.: | EP0984773 | Date: | 15.03.2000 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.12.1998 takes the place of the publication of the European patent application. | [2000/11] | Type: | B1 Patent specification | No.: | EP0984773 | Date: | 12.03.2003 | Language: | EN | [2003/11] | Search report(s) | International search report - published on: | SE | 03.12.1998 | Classification | IPC: | A61K9/28, A61K31/44 | [2000/11] | CPC: |
A61K31/4439 (EP,US);
A61K9/28 (KR);
A61K9/1676 (EP,US);
A61K9/5073 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/11] | Extension states | LT | 28.12.1999 | LV | 28.12.1999 | MK | 28.12.1999 | RO | 28.12.1999 | SI | 28.12.1999 | Title | German: | PHARMAZEUTISCHE OMEPRAZOL-FORMULIERUNG | [2000/11] | English: | PHARMACEUTICAL FORMULATION OF OMEPRAZOLE | [2000/11] | French: | FORMULATION PHARMACEUTIQUE D'OMEPRAZOLE | [2000/11] | Entry into regional phase | 28.12.1999 | National basic fee paid | 28.12.1999 | Designation fee(s) paid | 28.12.1999 | Examination fee paid | Examination procedure | 14.12.1998 | Request for preliminary examination filed International Preliminary Examining Authority: SE | 28.12.1999 | Examination requested [2000/11] | 30.08.2002 | Communication of intention to grant the patent | 19.12.2002 | Fee for grant paid | 19.12.2002 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
12.12.2003
22.12.2003
ADMISSIBLE Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Best, Michael, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | [N/P] |
| Former [2004/06] | |||
| Opponent(s) | 01
12.12.2003
Ratiopharm GmbH 89070-Ulm / DE Opponent's representative Best, Michael, Dr., et al, et al Lederer & Keller Patentanwälte Prinzregentenstrasse 16 80538 München / DE | 16.01.2004 | Invitation to proprietor to file observations on the notice of opposition | 16.07.2004 | Reply of patent proprietor to notice(s) of opposition | 29.11.2005 | Date of oral proceedings | 31.01.2006 | Despatch of minutes of oral proceedings | 31.01.2006 | Date of despatch of rejection of opposition | 25.06.2010 | Legal effect of rejection of opposition [2013/33] | Appeal following opposition | 20.03.2006 | Appeal received No. T0414/06 | 09.06.2006 | Statement of grounds filed | 25.06.2010 | Result of appeal procedure: appeal of the opponent withdrawn | Fees paid | Renewal fee | 31.05.2000 | Renewal fee patent year 03 | 31.05.2001 | Renewal fee patent year 04 | 31.05.2002 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CH | 12.03.2003 | LI | 12.03.2003 | [2016/34] |
| Former [2014/10] | CH | 12.03.2003 | |
| LI | 12.03.2003 | ||
| Former [2013/33] | CH | 12.03.2003 | |
| LI | 12.03.2003 | ||
| Former [2004/31] | FR | 30.01.2004 | Cited in | International search | [A]EP0247983 (HAESSLE AB [SE]); | [A]US5372998 (KOKUBO HIROYASU [JP], et al); | [A]WO9601623 (ASTRA AB [SE], et al) |